- $23.60m
- -$2.64m
- $86.77m
- 68
- 95
- 29
- 69
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.82 | ||
| Price to Tang. Book | 2.16 | ||
| Price to Free Cashflow | 12.46 | ||
| Price to Sales | 0.26 | ||
| EV to EBITDA | -3.12 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.59% | ||
| Return on Equity | 3.49% | ||
| Operating Margin | 0.33% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 69.85 | 75.58 | 79.29 | 81.02 | 86.77 | n/a | n/a | 2.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +596.67 | +342.04 | -57.65 | -50.27 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vaso Corporation principally operates in the healthcare equipment and information technology (IT) industries. The Company's segments include IT, Professional sales service, and Equipment. The IT segment, operating through a wholly owned subsidiary VasoTechnology, Inc., primarily focuses on healthcare IT and managed network technology services. The Professional sales service segment, operating through a wholly owned subsidiary, Vaso Diagnostics, Inc., also known as VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for GE HealthCare Technologies, Inc. into the health provider middle market. The Equipment segment primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through a wholly owned subsidiary VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.
Directors
- Joshua Markowitz NEC (65)
- Jun Ma CEO (57)
- David Lieberman VCH (76)
- Jonathan Newton CFO (60)
- Michael Beecher CFO (75)
- Jane Moen CEX (41)
- Peter Castle COO (52)
- Behnam Movaseghi IND (67)
- Edgar Rios IND (68)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 22nd, 1987
- Public Since
- December 1st, 1988
- No. of Shareholders
- 900
- No. of Employees
- 298
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq- Shares in Issue
- 175,696,311
- Address
- 137 Commercial St Ste 200, PLAINVIEW, 11803-2410
- Web
- https://vasocorporation.com/
- Phone
- +1 5169974600
- Auditors
- UHY LLP
Upcoming Events for VASO
Q2 2025 Vaso Corp Earnings Release
Similar to VASO
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
What is the Vaso share price?
As of Today at 05:56 UTC, shares in Vaso are trading at $0.13. This share price information is delayed by 15 minutes.
How has the Vaso share price performed this year?
Shares in Vaso last closed at $0.13 and the price had moved by -53.69% over the past 365 days. In terms of relative price strength the Vaso share price has underperformed the S&P500 Index by -56.73% over the past year.
What are the analyst and broker recommendations for Vaso?
There is no consensus recommendation for this security.
Find out moreWhat is the Vaso dividend yield?
Vaso does not currently pay a dividend.
Does Vaso pay a dividend?
Vaso does not currently pay a dividend.
When does Vaso next pay dividends?
Vaso does not currently pay a dividend.
How do I buy Vaso shares?
To buy shares in Vaso you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vaso?
As of the previous close price of $0.13, shares in Vaso had a market capitalisation of $22.77m.
Where are Vaso shares listed?
Here are the trading details for Vaso:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: VASO
What kind of share is Vaso?
Based on an overall assessment of its quality, value and momentum Vaso is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vaso share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Vaso share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vaso. Over the past six months, its share price has underperformed the S&P500 Index by -10.91%.
As of the last closing price of $0.13, shares in Vaso were trading -21.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vaso PE Ratio?
The Vaso PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.13.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vaso?
Vaso's management team is headed by:
- Joshua Markowitz - NEC
- Jun Ma - CEO
- David Lieberman - VCH
- Jonathan Newton - CFO
- Michael Beecher - CFO
- Jane Moen - CEX
- Peter Castle - COO
- Behnam Movaseghi - IND
- Edgar Rios - IND